Document is current

Article History

Received: 26 July 2024

Accepted: 15 November 2024

First Online: 30 December 2024

Declarations

:

: Not applicable.

: Not applicable.

: Dr. Philippe Bégin has received consulting fees and honoraria from ALK, Astra Zeneca, Sanofi, Bausch Health, Pfizer. He is also a clinical trial investigator with DBV Technologies (Viaskin Patch), Regeneron, Novartis, ALK, and Sanofi. He is on the Board of Directors of the CSACI, AAIQ and CAAIF and medical advisor to Food Allergy Canada. Dr. Susan Waserman has received consulting fees and honoraria from AstraZeneca, GlaxoSmithKline, Novartis, ALK, Bausch Health, Mylan, Meda, CSL Behring, Takeda, Pfizer, Sanofi, Medexus Pharma, and Miravo. She is a clinical trial investigator for Aimmune. She is the President of CAAIF, on the Board of Directors of Asthma Canada, and medical advisor to Food Allergy Canada. Dr. Jennifer Protudjer is Section Head for Allied Health, and Co-Lead, Research Pullar, for the Canadian Society of Allergy and Clinical Immunology; sits on the steering committee for Canada’s National Food Allergy Action Plan, and reports consultancy for Nutricia, Novartis, Ajinomoto Cambrooke and ALK-Abelló. Dr. Samira Jeimy has received consulting fees and honoraria from Sanofi, GSK, Miravo, AstraZeneca, Medexus, Stallergenes Greer and Novartis. Dr. Wade Watson is medical advisor to Food Allergy Canada.